StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) Tops Analyst Estimates on Strong Keytruda, Gardasil, and Bridion Sales
July 28, 2022 2:03 PM
Merck's (NYSE: MRK) shares dipped in the early part of Thursday's session after it reported second-quarter earnings. Profit and revenue ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Earnings
Hot List
Next Articles
Merck (MRK) Tops Q2 EPS by 19c; Raises and Narrows FY Sales Guidance, Narrows EPS
July 28, 2022 6:37 AM
Merck profit tops Wall Street view on strong Keytruda sales
July 28, 2022 6:32 AM
Merck Announces Second-Quarter 2022 Financial Results
July 28, 2022 6:30 AM
Merck (MRK), Abbott (ABT) must comply with the Senate panel's tax probe, Wyden says - Bloomberg
July 27, 2022 1:04 PM
Merck (MRK) weekly option IV bid into quarter results and outlook
July 27, 2022 11:00 AM
Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator
July 27, 2022 10:07 AM
Merck (MRK) July weekly 91 straddle priced for a move of 4% into quarter results
July 27, 2022 5:22 AM
